CanSino Biologics Inc. (HKG: 6185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
29.95
-0.10 (-0.33%)
Nov 15, 2024, 10:48 AM HKT

CanSino Biologics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
-720.11-1,483-909.431,914-396.64-156.78
Upgrade
Depreciation & Amortization
263.24263.24189.2273.3624.5918.54
Upgrade
Other Amortization
69.6569.657.1415.187.223.93
Upgrade
Loss (Gain) From Sale of Assets
-0.02-0.02----
Upgrade
Asset Writedown & Restructuring Costs
362.7362.70.250.250.530.26
Upgrade
Loss (Gain) From Sale of Investments
-42.63-42.63-76.63-71.86-38.68-3.91
Upgrade
Stock-Based Compensation
9.549.5410.089.8--
Upgrade
Provision & Write-off of Bad Debts
15.0515.058.781.82--
Upgrade
Other Operating Activities
-224.4476.62624.87-6.5843.5-40.04
Upgrade
Change in Accounts Receivable
265.97265.97-495.8-419.94-107.76-8.59
Upgrade
Change in Inventory
-216.54-216.54-604.02-706.39-154.57-8.08
Upgrade
Change in Accounts Payable
-223.19-223.19-429.931,212155.58-2.48
Upgrade
Change in Unearned Revenue
-5.64-5.6420.8827.52--
Upgrade
Change in Other Net Operating Assets
11.211.2--2.1142.92
Upgrade
Operating Cash Flow
-446.67-908.23-1,8522,050-349.93-154.25
Upgrade
Capital Expenditures
-489.24-610.47-1,075-1,203-288.29-116.92
Upgrade
Sale of Property, Plant & Equipment
0.30.31---0.01
Upgrade
Cash Acquisitions
0.04-0.34----
Upgrade
Investment in Securities
-1,79799.25-697.83-1,403-60.06-709.94
Upgrade
Other Investing Activities
1,39261.59545.2145.7728.6613.16
Upgrade
Investing Cash Flow
-893.84-449.65-1,228-2,560-319.69-813.7
Upgrade
Short-Term Debt Issued
-50.46----
Upgrade
Long-Term Debt Issued
-1,6352,6341,150--
Upgrade
Total Debt Issued
1,0741,6852,6341,150--
Upgrade
Short-Term Debt Repaid
--20.58----
Upgrade
Long-Term Debt Repaid
--1,615-1,388-181-22.49-7.3
Upgrade
Total Debt Repaid
-1,111-1,636-1,388-181-22.49-7.3
Upgrade
Net Debt Issued (Repaid)
-37.7649.181,246969.13-22.49-7.3
Upgrade
Issuance of Common Stock
16.9816.98--4,9841,128
Upgrade
Repurchase of Common Stock
---150.17---
Upgrade
Common Dividends Paid
-65.11-73.75-241.28-14.1-6.69-8.78
Upgrade
Other Financing Activities
-23.28--0.37598.59-13.55-20.86
Upgrade
Financing Cash Flow
-109.17-7.58854.231,5544,9411,091
Upgrade
Foreign Exchange Rate Adjustments
-32.3920.29160.76-33.78-27.3621.72
Upgrade
Net Cash Flow
-1,482-1,345-2,0641,0094,244144.6
Upgrade
Free Cash Flow
-935.9-1,519-2,927846.86-638.23-271.17
Upgrade
Free Cash Flow Margin
-125.03%-425.31%-282.87%19.70%-2564.19%-11875.88%
Upgrade
Free Cash Flow Per Share
-3.79-6.16-11.843.42-2.77-1.31
Upgrade
Cash Income Tax Paid
46.42-24.05-77.91-162.45-5.99-3.57
Upgrade
Levered Free Cash Flow
-1,191-846.51-2,557185.99-556.69-244.26
Upgrade
Unlevered Free Cash Flow
-1,150-806.42-2,531198.76-556.69-244.26
Upgrade
Change in Net Working Capital
305.79-538.18725.28-188.51-5.8135.13
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.